These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21509955)

  • 1. Enhanced productivity of NS0 cells in fed-batch culture with cholesterol nanoparticle supplementation.
    Wu Y; Ma N; Wyslouzil BE; Chalmers JJ; McCormick E; Casnocha SA
    Biotechnol Prog; 2011; 27(3):796-802. PubMed ID: 21509955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol delivery to NS0 cells: challenges and solutions in disposable linear low-density polyethylene-based bioreactors.
    Okonkowski J; Balasubramanian U; Seamans C; Fries S; Zhang J; Salmon P; Robinson D; Chartrain M
    J Biosci Bioeng; 2007 Jan; 103(1):50-9. PubMed ID: 17298901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a cholesterol-independent, non-GS NS0 cell line through chemical treatment and application for high titer antibody production.
    Li J; Gu W; Edmondson DG; Lu C; Vijayasankaran N; Figueroa B; Stevenson D; Ryll T; Li F
    Biotechnol Bioeng; 2012 Jul; 109(7):1685-92. PubMed ID: 22252532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
    Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
    Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fully defined, fed-batch, recombinant NS0 culture process for monoclonal antibody production.
    Hermes PA; Castro CD
    Biotechnol Prog; 2010; 26(5):1411-6. PubMed ID: 20540153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: Improved productivity and lactate metabolism.
    Ma N; Ellet J; Okediadi C; Hermes P; McCormick E; Casnocha S
    Biotechnol Prog; 2009; 25(5):1353-63. PubMed ID: 19637321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
    Frahm B; Lane P; Märkl H; Pörtner R
    Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis.
    Browne SM; Al-Rubeai M
    Biotechnol Bioeng; 2011 Apr; 108(4):880-92. PubMed ID: 21404261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NS0 cell damage by high gas velocity sparging in protein-free and cholesterol-free cultures.
    Zhu Y; Cuenca JV; Zhou W; Varma A
    Biotechnol Bioeng; 2008 Nov; 101(4):751-60. PubMed ID: 18814288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defined protein and animal component-free NS0 fed-batch culture.
    Spens E; Häggström L
    Biotechnol Bioeng; 2007 Dec; 98(6):1183-94. PubMed ID: 17516495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies.
    Sauer PW; Burky JE; Wesson MC; Sternard HD; Qu L
    Biotechnol Bioeng; 2000 Mar; 67(5):585-97. PubMed ID: 10649233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.
    Stansfield SH; Allen EE; Dinnis DM; Racher AJ; Birch JR; James DC
    Biotechnol Bioeng; 2007 Jun; 97(2):410-24. PubMed ID: 17115445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic low-density lipoprotein, a novel biomimetic lipid supplement for serum-free tissue culture.
    Hayavi S; Halbert GW
    Biotechnol Prog; 2005; 21(4):1262-8. PubMed ID: 16080710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of NS0 cells in protein-free, chemically defined medium.
    Gorfien S; Paul B; Walowitz J; Keem R; Biddle W; Jayme D
    Biotechnol Prog; 2000; 16(5):682-7. PubMed ID: 11027156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal NS0 cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber.
    Gramer MJ; Maas J
    Biotechnol Prog; 2003; 19(6):1762-6. PubMed ID: 14656153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system.
    Ohashi R; Otero JM; Chwistek A; Yamato I; Hamel JF
    Biotechnol Prog; 2002; 18(6):1292-300. PubMed ID: 12467465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level production of a monoclonal antibody in murine myeloma cells by perfusion culture using a gravity settler.
    Choo CY; Tian Y; Kim WS; Blatter E; Conary J; Brady CP
    Biotechnol Prog; 2007; 23(1):225-31. PubMed ID: 17269692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.